BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 34692847)

  • 1. Potential lncRNA Biomarkers for HBV-Related Hepatocellular Carcinoma Diagnosis Revealed by Analysis on Coexpression Network.
    Nong S; Chen X; Wang Z; Xu G; Wei W; Peng B; Zhou L; Wei L; Zhao J; Wei Q; Deng Y; Meng L
    Biomed Res Int; 2021; 2021():9972011. PubMed ID: 34692847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
    Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC.
    Huang K; Lu Z; Li L; Peng G; Zhou W; Ye Q
    Hum Cell; 2021 Nov; 34(6):1830-1842. PubMed ID: 34487338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of diagnostic long non‑coding RNA biomarkers in patients with hepatocellular carcinoma.
    Li G; Shi H; Wang X; Wang B; Qu Q; Geng H; Sun H
    Mol Med Rep; 2019 Aug; 20(2):1121-1130. PubMed ID: 31173205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
    Yu Y; Cheng J; Mei CZ; Dai YZ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Chen X; Liao L; Li Y; Huang H; Huang Q; Deng S
    Biomed Res Int; 2020; 2020():7653506. PubMed ID: 33102593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring new targets for the treatment of hepatitis-B virus and hepatitis-B virus-associated hepatocellular carcinoma: A new perspective in bioinformatics.
    Wang Y; Wang S; Che Y; Chen D; Liu Y; Shi Y
    Medicine (Baltimore); 2021 Aug; 100(33):e26917. PubMed ID: 34414947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of long non-coding RNA expression profiles in hepatitis B virus-related hepatocellular carcinoma.
    Gong X; Wei W; Chen L; Xia Z; Yu C
    Oncotarget; 2016 Jul; 7(27):42422-42430. PubMed ID: 27285756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined identification of three lncRNAs in serum as effective diagnostic and prognostic biomarkers for hepatitis B virus-related hepatocellular carcinoma.
    Fu P; Gong B; Li H; Luo Q; Huang Z; Shan R; Li J; Yan S
    Int J Cancer; 2022 Nov; 151(10):1824-1834. PubMed ID: 35802466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis.
    Xie S; Jiang X; Zhang J; Xie S; Hua Y; Wang R; Yang Y
    PeerJ; 2019; 7():e7408. PubMed ID: 31392101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic effect of a novel long noncoding RNA signature and comparison with clinical staging systems for patients with hepatitis B virus-related hepatocellular carcinoma after hepatectomy.
    Wu H; Liu TT; Feng YM; Xie XY; Su XN; Qi JN; Zhu Q; Qin CY
    J Dig Dis; 2020 Nov; 21(11):650-663. PubMed ID: 32959529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 15. Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV.
    Lu J; Xie F; Geng L; Shen W; Sui C; Yang J
    Tumour Biol; 2015 May; 36(5):3231-6. PubMed ID: 25501706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Novel Eight-lncRNA Prognostic Signature for HBV-HCC and Analysis of Their Functions Based on Coexpression and ceRNA Networks.
    Zhao X; Bai Z; Li C; Sheng C; Li H
    Biomed Res Int; 2020; 2020():8765461. PubMed ID: 32382578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of 5 Hub Genes Related to the Early Diagnosis, Tumour Stage, and Poor Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis.
    Qiang R; Zhao Z; Tang L; Wang Q; Wang Y; Huang Q
    Comput Math Methods Med; 2021; 2021():9991255. PubMed ID: 34603487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of a TPX2-related TRHDE-AS1/PKIA ceRNA network involving prognostic signatures in Hepatitis B virus-infected hepatocellular carcinoma.
    Li G; Wang Z; Chen D; Yin J; Mo Z; Sun B; Yang T; Zhang X; Zhai Z; Li Y; Chen P; Dai Y; Wang Z; Ma J
    Front Cell Infect Microbiol; 2022; 12():1025900. PubMed ID: 36204642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 9‑lncRNA risk score system for predicting the prognosis of patients with hepatitis B virus‑positive hepatocellular carcinoma.
    Liu H; Zhao P; Jin X; Zhao Y; Chen Y; Yan T; Wang J; Wu L; Sun Y
    Mol Med Rep; 2019 Jul; 20(1):573-583. PubMed ID: 31115573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
    Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
    J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.